Skip to content
10-Q

Quarterly Report

Verona Pharma plc

0001657312-25-000020

← back to feed
Filed
Apr 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 23, 2025 681.06M sh
Shares Diluted Q1 2025 · Mar 31, 2025 679.41M sh
Shares Diluted Q1 2025 · Mar 31, 2024 645.7M sh
Capex Q1 2025 · Mar 31, 2025 $535K
Capex Q1 2025 · Mar 31, 2024 $16K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$11.56M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$13.61M
Long Term Debt Q1 2025 · Mar 31, 2025 $241.74M
Long Term Debt Q1 2025 · Dec 31, 2024 $120.34M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $401.42M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $399.76M
Stockholders Equity Q1 2025 · Mar 31, 2025 $226.6M
Stockholders Equity Q1 2025 · Dec 31, 2024 $204.56M
Stockholders Equity Q1 2025 · Mar 31, 2024 $224.99M
Stockholders Equity Q1 2025 · Dec 31, 2023 $249.28M
Current Liabilities Q1 2025 · Mar 31, 2025 $56.54M
Current Liabilities Q1 2025 · Dec 31, 2024 $42.68M
Total Liabilities Q1 2025 · Mar 31, 2025 $299.34M
Total Liabilities Q1 2025 · Dec 31, 2024 $269.68M
Current Assets Q1 2025 · Mar 31, 2025 $501.03M
Current Assets Q1 2025 · Dec 31, 2024 $453.57M
Total Assets Q1 2025 · Mar 31, 2025 $525.94M
Total Assets Q1 2025 · Dec 31, 2024 $474.24M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.02
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.04
Eps Basic Q1 2025 · Mar 31, 2025 −$0.02
Eps Basic Q1 2025 · Mar 31, 2024 −$0.04
Sga Expense Q1 2025 · Mar 31, 2025 $69.11M
Sga Expense Q1 2025 · Mar 31, 2024 $20.43M
Rd Expense Q1 2025 · Mar 31, 2025 $14.05M
Rd Expense Q1 2025 · Mar 31, 2024 $6.76M
Net Income Q1 2025 · Mar 31, 2025 −$16.32M
Net Income Q1 2025 · Mar 31, 2024 −$25.79M
Operating Income Q1 2025 · Mar 31, 2025 −$10.32M
Operating Income Q1 2025 · Mar 31, 2024 −$27.2M
Revenue Q1 2025 · Mar 31, 2025 $76.26M
Revenue Q1 2025 · Mar 31, 2024 $0